19234680

Source:http://linkedlifedata.com/resource/pubmed/id/19234680

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027686, umls-concept:C0030705, umls-concept:C0205210, umls-concept:C0332293, umls-concept:C0348014, umls-concept:C0796392, umls-concept:C1274040, umls-concept:C1522223
pubmed:issue	2
pubmed:dateCreated	2009-3-24
pubmed:abstractText	The purpose of this study was to evaluate the clinical outcomes of patients with anterior segment neovascularization treated with or without intravitreal bevacizumab.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8611864
pubmed:citationSubset	T
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1865-8652
pubmed:author	pubmed-author:CalzadaJorge IJI, pubmed-author:CharlesSteveS, pubmed-author:LupinacciAlvaro P CAP, pubmed-author:NetlandPeter APA, pubmed-author:RafieeteryMohammadM
pubmed:issnType	Electronic
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	208-16
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19234680-Aged, pubmed-meshheading:19234680-Aged, 80 and over, pubmed-meshheading:19234680-Analysis of Variance, pubmed-meshheading:19234680-Angiogenesis Inhibitors, pubmed-meshheading:19234680-Antibodies, Monoclonal, pubmed-meshheading:19234680-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19234680-Chi-Square Distribution, pubmed-meshheading:19234680-Female, pubmed-meshheading:19234680-Glaucoma, Neovascular, pubmed-meshheading:19234680-Gonioscopy, pubmed-meshheading:19234680-Humans, pubmed-meshheading:19234680-Injections, Intraocular, pubmed-meshheading:19234680-Intraocular Pressure, pubmed-meshheading:19234680-Iris, pubmed-meshheading:19234680-Linear Models, pubmed-meshheading:19234680-Male, pubmed-meshheading:19234680-Middle Aged, pubmed-meshheading:19234680-Neovascularization, Pathologic, pubmed-meshheading:19234680-Retrospective Studies, pubmed-meshheading:19234680-Statistics, Nonparametric, pubmed-meshheading:19234680-Trabeculectomy, pubmed-meshheading:19234680-Treatment Outcome, pubmed-meshheading:19234680-Visual Acuity
pubmed:year	2009
pubmed:articleTitle	Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.
pubmed:affiliation	Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
pubmed:publicationType	Journal Article